FMP

FMP

Enter

ASND - Ascendis Pharma A/S

Financial Summary of Ascendis Pharma A/S(ASND), Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medic

photo-url-https://financialmodelingprep.com/image-stock/ASND.png

Ascendis Pharma A/S

ASND

NASDAQ

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/g for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

140.17 USD

-0.72 (-0.514%)

About

ceo

Mr. Jan Moller Mikkelsen

sector

Healthcare

industry

Biotechnology

website

https://ascendispharma.com

exchange

NASDAQ

Description

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/g for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

CIK

0001612042

ISIN

US04351P1012

CUSIP

04351P101

Address

Tuborg Boulevard 12

Phone

45 70 22 22 44

Country

DK

Employee

879

IPO Date

Jan 28, 2015

Summary

CIK

0001612042

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

04351P101

ISIN

US04351P1012

Country

DK

Price

140.17

Beta

0.51

Volume Avg.

355.5k

Market Cap

7.94B

Shares

-

52-Week

66.03-161.0

DCF

-80.97

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-15.35

P/B

-

Website

https://ascendispharma.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest ASND News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep